Songthip Ounpraseuth
Concepts (393)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ultrasonography, Prenatal | 10 | 2021 | 160 | 2.310 |
Why?
| Amniotic Fluid | 9 | 2020 | 70 | 2.200 |
Why?
| Heart Failure | 8 | 2022 | 528 | 1.720 |
Why?
| Neonatal Abstinence Syndrome | 7 | 2024 | 28 | 1.440 |
Why?
| Pregnancy | 42 | 2024 | 2452 | 1.370 |
Why?
| Fetal Membranes, Premature Rupture | 5 | 2021 | 22 | 1.200 |
Why?
| Cocaine-Related Disorders | 6 | 2019 | 209 | 1.130 |
Why?
| Female | 86 | 2025 | 27081 | 1.110 |
Why?
| Oligohydramnios | 6 | 2020 | 41 | 1.040 |
Why?
| Humans | 106 | 2025 | 50503 | 0.950 |
Why?
| Stereotyping | 3 | 2019 | 33 | 0.890 |
Why?
| Religion | 2 | 2014 | 62 | 0.860 |
Why?
| Infant, Newborn | 23 | 2024 | 2749 | 0.850 |
Why?
| Insurance, Health | 3 | 2019 | 128 | 0.820 |
Why?
| Quality of Life | 6 | 2020 | 851 | 0.780 |
Why?
| Attitude of Health Personnel | 5 | 2022 | 352 | 0.780 |
Why?
| Health Personnel | 4 | 2020 | 247 | 0.760 |
Why?
| Adult | 45 | 2025 | 13577 | 0.760 |
Why?
| Advance Directives | 3 | 2023 | 29 | 0.750 |
Why?
| Substance-Related Disorders | 7 | 2019 | 611 | 0.730 |
Why?
| Caregivers | 2 | 2022 | 217 | 0.730 |
Why?
| Placenta Accreta | 1 | 2021 | 25 | 0.710 |
Why?
| Health Knowledge, Attitudes, Practice | 5 | 2022 | 491 | 0.710 |
Why?
| Analgesics, Opioid | 8 | 2024 | 575 | 0.700 |
Why?
| Length of Stay | 4 | 2024 | 629 | 0.690 |
Why?
| Rural Population | 13 | 2022 | 554 | 0.680 |
Why?
| Pregnancy Complications | 6 | 2023 | 380 | 0.680 |
Why?
| Medicaid | 6 | 2023 | 252 | 0.650 |
Why?
| Patient Preference | 1 | 2019 | 40 | 0.630 |
Why?
| Middle Aged | 32 | 2025 | 12611 | 0.620 |
Why?
| Delivery, Obstetric | 5 | 2020 | 109 | 0.610 |
Why?
| Mentally Ill Persons | 1 | 2018 | 14 | 0.600 |
Why?
| Arkansas | 17 | 2022 | 1985 | 0.600 |
Why?
| Male | 44 | 2025 | 25907 | 0.600 |
Why?
| Prejudice | 1 | 2018 | 39 | 0.590 |
Why?
| Obstetrics | 4 | 2022 | 84 | 0.590 |
Why?
| Premature Birth | 5 | 2021 | 146 | 0.580 |
Why?
| Gestational Age | 11 | 2022 | 373 | 0.580 |
Why?
| Stillbirth | 3 | 2022 | 28 | 0.560 |
Why?
| Retrospective Studies | 26 | 2024 | 6263 | 0.560 |
Why?
| Sexual Behavior | 2 | 2017 | 117 | 0.550 |
Why?
| Placenta | 5 | 2022 | 134 | 0.530 |
Why?
| Hospitals | 2 | 2020 | 173 | 0.520 |
Why?
| Depression | 6 | 2019 | 582 | 0.500 |
Why?
| Telemedicine | 5 | 2022 | 469 | 0.500 |
Why?
| Hospitalization | 2 | 2017 | 675 | 0.490 |
Why?
| Pregnancy Outcome | 7 | 2021 | 207 | 0.480 |
Why?
| Inpatients | 1 | 2016 | 193 | 0.480 |
Why?
| United States | 21 | 2025 | 4955 | 0.480 |
Why?
| Cesarean Section | 5 | 2021 | 157 | 0.480 |
Why?
| Depressive Disorder | 1 | 2016 | 335 | 0.450 |
Why?
| Intensive Care Units, Neonatal | 4 | 2020 | 124 | 0.450 |
Why?
| Advance Care Planning | 2 | 2024 | 19 | 0.440 |
Why?
| United States Department of Veterans Affairs | 5 | 2024 | 291 | 0.430 |
Why?
| Opioid-Related Disorders | 3 | 2024 | 393 | 0.420 |
Why?
| Infant, Premature, Diseases | 1 | 2014 | 93 | 0.420 |
Why?
| Burnout, Professional | 2 | 2025 | 52 | 0.420 |
Why?
| Medical Records | 3 | 2024 | 85 | 0.410 |
Why?
| Veterans | 3 | 2024 | 574 | 0.410 |
Why?
| Vitamin D Deficiency | 2 | 2023 | 44 | 0.410 |
Why?
| Monte Carlo Method | 1 | 2012 | 85 | 0.400 |
Why?
| Vaccines | 2 | 2023 | 50 | 0.400 |
Why?
| Healthcare Disparities | 3 | 2022 | 281 | 0.400 |
Why?
| Quality Indicators, Health Care | 3 | 2017 | 87 | 0.390 |
Why?
| Infant, Very Low Birth Weight | 1 | 2012 | 48 | 0.380 |
Why?
| Infant Mortality | 1 | 2012 | 57 | 0.380 |
Why?
| Aged | 19 | 2024 | 9741 | 0.380 |
Why?
| Longitudinal Studies | 7 | 2020 | 735 | 0.370 |
Why?
| Research Design | 5 | 2022 | 353 | 0.370 |
Why?
| Polyhydramnios | 4 | 2019 | 24 | 0.360 |
Why?
| Blood Transfusion | 2 | 2021 | 129 | 0.340 |
Why?
| Young Adult | 15 | 2021 | 4102 | 0.340 |
Why?
| Kidney Neoplasms | 2 | 2022 | 174 | 0.330 |
Why?
| Data Collection | 5 | 2024 | 280 | 0.330 |
Why?
| Birth Weight | 5 | 2020 | 106 | 0.330 |
Why?
| Mental Health Services | 3 | 2019 | 202 | 0.330 |
Why?
| Hair Color | 1 | 2009 | 10 | 0.320 |
Why?
| Mental Disorders | 3 | 2019 | 415 | 0.320 |
Why?
| Asthma | 2 | 2023 | 284 | 0.320 |
Why?
| Algorithms | 1 | 2012 | 625 | 0.320 |
Why?
| Adolescent | 13 | 2023 | 6443 | 0.310 |
Why?
| Congenital Abnormalities | 2 | 2021 | 112 | 0.310 |
Why?
| Logistic Models | 6 | 2024 | 900 | 0.300 |
Why?
| Gynecology | 2 | 2022 | 48 | 0.300 |
Why?
| Labor Stage, Third | 2 | 2018 | 19 | 0.300 |
Why?
| Predictive Value of Tests | 3 | 2019 | 930 | 0.300 |
Why?
| Postpartum Hemorrhage | 2 | 2018 | 34 | 0.290 |
Why?
| Image Processing, Computer-Assisted | 1 | 2009 | 243 | 0.290 |
Why?
| Viscosupplements | 2 | 2017 | 14 | 0.280 |
Why?
| Fatigue | 2 | 2019 | 127 | 0.280 |
Why?
| Hyaluronic Acid | 2 | 2017 | 34 | 0.280 |
Why?
| Obesity, Morbid | 2 | 2018 | 78 | 0.280 |
Why?
| Perinatal Care | 2 | 2020 | 25 | 0.270 |
Why?
| Adrenal Cortex Hormones | 2 | 2017 | 99 | 0.270 |
Why?
| Osteoarthritis, Knee | 2 | 2017 | 96 | 0.260 |
Why?
| Hypertension | 2 | 2021 | 544 | 0.250 |
Why?
| Dye Dilution Technique | 3 | 2014 | 14 | 0.240 |
Why?
| Schizophrenia | 2 | 2018 | 258 | 0.240 |
Why?
| PubMed | 1 | 2024 | 13 | 0.240 |
Why?
| Internship and Residency | 2 | 2022 | 447 | 0.240 |
Why?
| Quality Control | 1 | 2024 | 98 | 0.230 |
Why?
| Breast Neoplasms | 1 | 2012 | 1201 | 0.210 |
Why?
| Opiate Substitution Treatment | 1 | 2024 | 99 | 0.210 |
Why?
| Alcohol Drinking | 3 | 2015 | 227 | 0.210 |
Why?
| Time Factors | 9 | 2023 | 2935 | 0.210 |
Why?
| Social Support | 3 | 2022 | 265 | 0.210 |
Why?
| Military Personnel | 1 | 2025 | 163 | 0.210 |
Why?
| Databases, Factual | 3 | 2020 | 673 | 0.210 |
Why?
| Pregnant Women | 1 | 2023 | 72 | 0.210 |
Why?
| Randomized Controlled Trials as Topic | 5 | 2023 | 573 | 0.200 |
Why?
| Pharmacies | 1 | 2023 | 60 | 0.200 |
Why?
| Labor, Obstetric | 2 | 2020 | 39 | 0.200 |
Why?
| Health Services Accessibility | 3 | 2019 | 424 | 0.200 |
Why?
| Substance Withdrawal Syndrome | 1 | 2023 | 168 | 0.200 |
Why?
| Medicare | 2 | 2022 | 247 | 0.200 |
Why?
| Peripartum Period | 1 | 2022 | 15 | 0.200 |
Why?
| Prescription Drugs | 1 | 2022 | 37 | 0.190 |
Why?
| Blood Volume | 2 | 2019 | 69 | 0.190 |
Why?
| Hypertension, Pregnancy-Induced | 1 | 2022 | 15 | 0.190 |
Why?
| Nurses | 1 | 2022 | 51 | 0.190 |
Why?
| Occupational Health | 1 | 2022 | 66 | 0.190 |
Why?
| Motor Activity | 2 | 2013 | 225 | 0.190 |
Why?
| Prospective Studies | 8 | 2023 | 2378 | 0.190 |
Why?
| Biomedical Research | 1 | 2024 | 244 | 0.190 |
Why?
| Hydroxyprogesterones | 1 | 2021 | 5 | 0.190 |
Why?
| Community Health Workers | 1 | 2021 | 51 | 0.190 |
Why?
| Infant | 6 | 2024 | 3628 | 0.190 |
Why?
| Carcinoma, Renal Cell | 1 | 2022 | 101 | 0.180 |
Why?
| Pregnancy Complications, Hematologic | 1 | 2021 | 13 | 0.180 |
Why?
| Reference Values | 2 | 2019 | 307 | 0.180 |
Why?
| Phenobarbital | 1 | 2021 | 17 | 0.180 |
Why?
| Clonidine | 1 | 2021 | 25 | 0.180 |
Why?
| Diabetes, Gestational | 1 | 2021 | 52 | 0.180 |
Why?
| HIV Infections | 2 | 2015 | 352 | 0.180 |
Why?
| Cross-Sectional Studies | 6 | 2023 | 1610 | 0.180 |
Why?
| Hysterectomy | 1 | 2021 | 88 | 0.180 |
Why?
| Parturition | 4 | 2023 | 49 | 0.180 |
Why?
| Hospitals, Teaching | 1 | 2020 | 54 | 0.180 |
Why?
| Amnion | 1 | 2020 | 9 | 0.180 |
Why?
| Morphine | 1 | 2021 | 101 | 0.180 |
Why?
| Neonatology | 1 | 2020 | 13 | 0.170 |
Why?
| Feasibility Studies | 5 | 2022 | 390 | 0.170 |
Why?
| Infant, Small for Gestational Age | 1 | 2020 | 32 | 0.170 |
Why?
| Self Efficacy | 2 | 2018 | 131 | 0.170 |
Why?
| Education, Medical | 1 | 2022 | 112 | 0.170 |
Why?
| Palliative Care | 1 | 2022 | 190 | 0.170 |
Why?
| Labor, Induced | 2 | 2020 | 16 | 0.170 |
Why?
| Pregnancy in Diabetics | 1 | 2020 | 26 | 0.170 |
Why?
| Pharmacists | 2 | 2011 | 145 | 0.170 |
Why?
| Anemia, Sickle Cell | 1 | 2021 | 94 | 0.170 |
Why?
| Analgesics | 1 | 2021 | 116 | 0.170 |
Why?
| Sex Factors | 3 | 2019 | 712 | 0.170 |
Why?
| Pilot Projects | 5 | 2022 | 698 | 0.170 |
Why?
| Fetus | 1 | 2020 | 183 | 0.170 |
Why?
| Primary Health Care | 2 | 2022 | 366 | 0.170 |
Why?
| Pre-Eclampsia | 2 | 2017 | 41 | 0.170 |
Why?
| Psychotherapy | 2 | 2017 | 110 | 0.160 |
Why?
| Risk Reduction Behavior | 2 | 2017 | 58 | 0.160 |
Why?
| Social Stigma | 2 | 2019 | 47 | 0.160 |
Why?
| Cohort Studies | 6 | 2020 | 1452 | 0.160 |
Why?
| Patient Care Team | 1 | 2021 | 258 | 0.160 |
Why?
| Propensity Score | 3 | 2017 | 136 | 0.160 |
Why?
| Blood Specimen Collection | 1 | 2019 | 35 | 0.160 |
Why?
| Medical Errors | 1 | 2019 | 23 | 0.160 |
Why?
| Community-Based Participatory Research | 2 | 2018 | 198 | 0.160 |
Why?
| Fetal Blood | 1 | 2019 | 66 | 0.150 |
Why?
| Education, Distance | 1 | 2019 | 42 | 0.150 |
Why?
| Sodium, Dietary | 1 | 2018 | 24 | 0.150 |
Why?
| Holistic Health | 1 | 2018 | 7 | 0.150 |
Why?
| Meditation | 1 | 2018 | 9 | 0.150 |
Why?
| Amphetamine-Related Disorders | 1 | 2019 | 93 | 0.150 |
Why?
| Aged, 80 and over | 4 | 2020 | 3226 | 0.140 |
Why?
| Surgical Wound Dehiscence | 1 | 2017 | 18 | 0.140 |
Why?
| Job Satisfaction | 2 | 2022 | 34 | 0.140 |
Why?
| Monitoring, Ambulatory | 1 | 2017 | 6 | 0.140 |
Why?
| Ultrasonography, Doppler, Color | 1 | 2017 | 31 | 0.140 |
Why?
| Medication Adherence | 1 | 2018 | 129 | 0.140 |
Why?
| Mandatory Programs | 1 | 2017 | 21 | 0.140 |
Why?
| Remote Consultation | 1 | 2017 | 28 | 0.140 |
Why?
| Condoms | 1 | 2017 | 23 | 0.140 |
Why?
| Physicians | 1 | 2020 | 232 | 0.140 |
Why?
| Focus Groups | 1 | 2018 | 194 | 0.140 |
Why?
| Aftercare | 1 | 2017 | 72 | 0.140 |
Why?
| Respiratory Distress Syndrome, Newborn | 1 | 2017 | 49 | 0.140 |
Why?
| Surgical Wound Infection | 1 | 2017 | 115 | 0.130 |
Why?
| Pregnancy, High-Risk | 2 | 2017 | 49 | 0.130 |
Why?
| Diabetes Mellitus | 1 | 2020 | 279 | 0.130 |
Why?
| Arthroplasty, Replacement, Knee | 2 | 2017 | 285 | 0.130 |
Why?
| Postpartum Period | 1 | 2017 | 102 | 0.130 |
Why?
| Behavior Therapy | 1 | 2017 | 185 | 0.130 |
Why?
| Stress, Psychological | 1 | 2018 | 266 | 0.130 |
Why?
| Insurance Coverage | 1 | 2017 | 110 | 0.130 |
Why?
| Patient Satisfaction | 1 | 2017 | 278 | 0.120 |
Why?
| Health Education | 1 | 2017 | 153 | 0.120 |
Why?
| Reproducibility of Results | 4 | 2024 | 1197 | 0.120 |
Why?
| Body Weight | 2 | 2017 | 517 | 0.120 |
Why?
| Autistic Disorder | 1 | 2017 | 126 | 0.120 |
Why?
| Health Promotion | 1 | 2017 | 258 | 0.120 |
Why?
| Sexually Transmitted Diseases, Viral | 1 | 2014 | 8 | 0.120 |
Why?
| Body Mass Index | 4 | 2020 | 677 | 0.120 |
Why?
| Risk Assessment | 1 | 2019 | 1270 | 0.120 |
Why?
| Fetal Weight | 1 | 2014 | 10 | 0.110 |
Why?
| Fetal Macrosomia | 1 | 2014 | 17 | 0.110 |
Why?
| Gravidity | 1 | 2013 | 5 | 0.110 |
Why?
| Risk-Taking | 1 | 2014 | 107 | 0.110 |
Why?
| Rural Health | 1 | 2014 | 89 | 0.110 |
Why?
| Veterans Health | 2 | 2024 | 62 | 0.110 |
Why?
| Referral and Consultation | 2 | 2012 | 288 | 0.110 |
Why?
| Public Health | 1 | 2015 | 199 | 0.110 |
Why?
| Treatment Outcome | 3 | 2020 | 5283 | 0.110 |
Why?
| Vitamins | 2 | 2023 | 63 | 0.100 |
Why?
| Risk Factors | 4 | 2018 | 3724 | 0.100 |
Why?
| Vitamin D | 2 | 2023 | 87 | 0.100 |
Why?
| Sleep | 2 | 2024 | 181 | 0.100 |
Why?
| Selection Bias | 1 | 2012 | 15 | 0.100 |
Why?
| Alcohol-Related Disorders | 1 | 2012 | 43 | 0.100 |
Why?
| Child | 5 | 2023 | 6906 | 0.100 |
Why?
| Urination | 1 | 2011 | 19 | 0.100 |
Why?
| Osmolar Concentration | 1 | 2011 | 62 | 0.100 |
Why?
| Contraception, Postcoital | 1 | 2011 | 8 | 0.100 |
Why?
| Computer Simulation | 1 | 2012 | 279 | 0.100 |
Why?
| Preceptorship | 1 | 2011 | 19 | 0.090 |
Why?
| Survivors | 1 | 2012 | 128 | 0.090 |
Why?
| Prenatal Care | 2 | 2024 | 106 | 0.090 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 405 | 0.090 |
Why?
| Deglutition | 1 | 2011 | 43 | 0.090 |
Why?
| Quality Improvement | 2 | 2024 | 209 | 0.090 |
Why?
| Infant, Premature | 1 | 2014 | 317 | 0.090 |
Why?
| Substance Abuse Treatment Centers | 1 | 2011 | 79 | 0.090 |
Why?
| Risk | 1 | 2012 | 324 | 0.090 |
Why?
| Energy Metabolism | 1 | 2013 | 286 | 0.090 |
Why?
| Health Services Needs and Demand | 1 | 2012 | 156 | 0.090 |
Why?
| Models, Statistical | 1 | 2012 | 226 | 0.090 |
Why?
| Pharmacy | 1 | 2011 | 54 | 0.090 |
Why?
| Program Evaluation | 3 | 2019 | 349 | 0.090 |
Why?
| Career Choice | 1 | 2011 | 112 | 0.090 |
Why?
| Skin Neoplasms | 2 | 2008 | 491 | 0.090 |
Why?
| Linear Models | 2 | 2021 | 279 | 0.090 |
Why?
| Gene Expression | 1 | 2012 | 610 | 0.090 |
Why?
| Motivation | 1 | 2012 | 275 | 0.080 |
Why?
| Methods | 1 | 2009 | 55 | 0.080 |
Why?
| Color | 1 | 2009 | 22 | 0.080 |
Why?
| Central Nervous System Stimulants | 1 | 2011 | 209 | 0.080 |
Why?
| Pandemics | 2 | 2025 | 563 | 0.080 |
Why?
| Head and Neck Neoplasms | 1 | 2012 | 287 | 0.080 |
Why?
| Clinical Competence | 2 | 2022 | 398 | 0.080 |
Why?
| Patient Education as Topic | 1 | 2011 | 320 | 0.080 |
Why?
| Parity | 2 | 2020 | 43 | 0.070 |
Why?
| Keratinocytes | 1 | 2008 | 77 | 0.070 |
Why?
| Gene Expression Profiling | 1 | 2012 | 1025 | 0.070 |
Why?
| Lung | 1 | 2011 | 504 | 0.070 |
Why?
| Precancerous Conditions | 1 | 2008 | 82 | 0.070 |
Why?
| Carcinoma in Situ | 1 | 2008 | 73 | 0.070 |
Why?
| Prognosis | 1 | 2012 | 1978 | 0.070 |
Why?
| Injections, Intra-Articular | 2 | 2017 | 36 | 0.070 |
Why?
| Fatty Acids, Omega-3 | 1 | 2007 | 28 | 0.070 |
Why?
| Arteriovenous Shunt, Surgical | 1 | 2007 | 30 | 0.070 |
Why?
| Orthopedic Procedures | 2 | 2017 | 70 | 0.070 |
Why?
| Social Work | 2 | 2017 | 23 | 0.060 |
Why?
| Knee Joint | 2 | 2017 | 164 | 0.060 |
Why?
| Epigenesis, Genetic | 1 | 2009 | 372 | 0.060 |
Why?
| Severity of Illness Index | 2 | 2023 | 978 | 0.060 |
Why?
| Aircraft | 1 | 2025 | 9 | 0.060 |
Why?
| Regression Analysis | 2 | 2018 | 382 | 0.060 |
Why?
| Workload | 1 | 2025 | 45 | 0.060 |
Why?
| Nomograms | 1 | 2024 | 6 | 0.060 |
Why?
| Carcinoma, Squamous Cell | 1 | 2008 | 326 | 0.060 |
Why?
| Mississippi | 2 | 2015 | 85 | 0.060 |
Why?
| Health Services Research | 2 | 2019 | 152 | 0.060 |
Why?
| Thrombosis | 1 | 2007 | 250 | 0.060 |
Why?
| Cholecalciferol | 1 | 2023 | 22 | 0.060 |
Why?
| Pregnancy Trimester, Third | 2 | 2014 | 50 | 0.060 |
Why?
| Dietary Supplements | 2 | 2023 | 449 | 0.050 |
Why?
| Vaccines, DNA | 1 | 2003 | 12 | 0.050 |
Why?
| Methadone | 1 | 2024 | 183 | 0.050 |
Why?
| Educational Status | 2 | 2017 | 230 | 0.050 |
Why?
| Obesity | 2 | 2022 | 1121 | 0.050 |
Why?
| Morbidity | 1 | 2023 | 130 | 0.050 |
Why?
| Patient-Centered Care | 1 | 2024 | 130 | 0.050 |
Why?
| Self Report | 2 | 2015 | 206 | 0.050 |
Why?
| Plasmids | 1 | 2003 | 164 | 0.050 |
Why?
| Practice Guidelines as Topic | 2 | 2017 | 468 | 0.050 |
Why?
| Fetal Death | 1 | 2022 | 20 | 0.050 |
Why?
| Autopsy | 1 | 2022 | 47 | 0.050 |
Why?
| Narcotics | 1 | 2023 | 112 | 0.050 |
Why?
| Buprenorphine | 1 | 2024 | 145 | 0.050 |
Why?
| Cancer Vaccines | 1 | 2003 | 80 | 0.050 |
Why?
| Sample Size | 1 | 2022 | 39 | 0.050 |
Why?
| Interviews as Topic | 2 | 2015 | 272 | 0.050 |
Why?
| Breast Feeding | 1 | 2024 | 189 | 0.050 |
Why?
| Eating | 1 | 2023 | 158 | 0.050 |
Why?
| Multicenter Studies as Topic | 1 | 2022 | 89 | 0.050 |
Why?
| Decision Making | 1 | 2024 | 272 | 0.050 |
Why?
| Republic of Korea | 1 | 2022 | 89 | 0.050 |
Why?
| Uterine Hemorrhage | 1 | 2021 | 8 | 0.050 |
Why?
| Comorbidity | 1 | 2023 | 623 | 0.050 |
Why?
| Academic Medical Centers | 2 | 2012 | 149 | 0.050 |
Why?
| Health Care Costs | 1 | 2022 | 167 | 0.050 |
Why?
| Prenatal Diagnosis | 1 | 2021 | 97 | 0.050 |
Why?
| Suicidal Ideation | 1 | 2022 | 97 | 0.050 |
Why?
| Self Care | 1 | 2022 | 135 | 0.050 |
Why?
| Emergencies | 1 | 2021 | 79 | 0.040 |
Why?
| Prevalence | 1 | 2023 | 971 | 0.040 |
Why?
| Vaccination | 1 | 2022 | 280 | 0.040 |
Why?
| Drug Administration Schedule | 1 | 2021 | 370 | 0.040 |
Why?
| Symptom Assessment | 1 | 2020 | 32 | 0.040 |
Why?
| Melanoma | 1 | 2003 | 280 | 0.040 |
Why?
| Drug Therapy, Combination | 1 | 2021 | 384 | 0.040 |
Why?
| Triage | 1 | 2020 | 60 | 0.040 |
Why?
| Weight Loss | 1 | 2021 | 245 | 0.040 |
Why?
| Erythroid Precursor Cells | 1 | 2019 | 15 | 0.040 |
Why?
| Forecasting | 1 | 2020 | 147 | 0.040 |
Why?
| Crack Cocaine | 1 | 2019 | 17 | 0.040 |
Why?
| Ohio | 1 | 2019 | 41 | 0.040 |
Why?
| Kentucky | 1 | 2019 | 47 | 0.040 |
Why?
| Case-Control Studies | 1 | 2022 | 1156 | 0.040 |
Why?
| Mice | 1 | 2009 | 5687 | 0.040 |
Why?
| Combined Modality Therapy | 1 | 2020 | 641 | 0.040 |
Why?
| Uterus | 1 | 2019 | 85 | 0.040 |
Why?
| Information Storage and Retrieval | 1 | 2019 | 61 | 0.040 |
Why?
| Education, Medical, Graduate | 1 | 2020 | 217 | 0.040 |
Why?
| Stroke Volume | 1 | 2019 | 141 | 0.040 |
Why?
| Ventricular Function, Left | 1 | 2019 | 169 | 0.040 |
Why?
| Postoperative Complications | 2 | 2017 | 1033 | 0.040 |
Why?
| Community-Institutional Relations | 1 | 2018 | 46 | 0.040 |
Why?
| Emergency Service, Hospital | 1 | 2022 | 484 | 0.040 |
Why?
| Southeastern United States | 1 | 2017 | 47 | 0.040 |
Why?
| Empathy | 1 | 2018 | 48 | 0.040 |
Why?
| Pulse | 1 | 2017 | 13 | 0.040 |
Why?
| Incidence | 1 | 2020 | 1032 | 0.040 |
Why?
| Molecular Weight | 1 | 2017 | 82 | 0.040 |
Why?
| Attitude to Computers | 1 | 2017 | 17 | 0.040 |
Why?
| Blood Pressure Monitoring, Ambulatory | 1 | 2017 | 36 | 0.030 |
Why?
| Cultural Competency | 1 | 2017 | 56 | 0.030 |
Why?
| Safe Sex | 1 | 2017 | 10 | 0.030 |
Why?
| Cross-Over Studies | 1 | 2017 | 228 | 0.030 |
Why?
| Community Health Services | 1 | 2017 | 101 | 0.030 |
Why?
| Telephone | 1 | 2017 | 69 | 0.030 |
Why?
| Mortality | 1 | 2017 | 96 | 0.030 |
Why?
| Methamphetamine | 1 | 2019 | 194 | 0.030 |
Why?
| Sexually Transmitted Diseases | 1 | 2017 | 36 | 0.030 |
Why?
| Diagnosis, Dual (Psychiatry) | 1 | 2016 | 41 | 0.030 |
Why?
| Follow-Up Studies | 2 | 2012 | 2242 | 0.030 |
Why?
| Income | 1 | 2017 | 104 | 0.030 |
Why?
| Disabled Children | 1 | 2017 | 62 | 0.030 |
Why?
| Chi-Square Distribution | 1 | 2017 | 277 | 0.030 |
Why?
| Curriculum | 1 | 2019 | 400 | 0.030 |
Why?
| Virginia | 1 | 2015 | 19 | 0.030 |
Why?
| Health Priorities | 1 | 2015 | 17 | 0.030 |
Why?
| Chorioamnionitis | 1 | 2015 | 15 | 0.030 |
Why?
| Qualitative Research | 1 | 2018 | 349 | 0.030 |
Why?
| Puerperal Disorders | 1 | 2015 | 22 | 0.030 |
Why?
| Racism | 1 | 2017 | 60 | 0.030 |
Why?
| Back Pain | 1 | 2015 | 38 | 0.030 |
Why?
| Unsafe Sex | 1 | 2015 | 25 | 0.030 |
Why?
| Poverty | 1 | 2017 | 208 | 0.030 |
Why?
| Sensitivity and Specificity | 1 | 2017 | 859 | 0.030 |
Why?
| Biophysical Phenomena | 1 | 2014 | 18 | 0.030 |
Why?
| Blood Pressure | 1 | 2017 | 531 | 0.030 |
Why?
| Oxygen | 1 | 2017 | 321 | 0.030 |
Why?
| Health Surveys | 1 | 2015 | 239 | 0.030 |
Why?
| Patient Compliance | 1 | 2015 | 233 | 0.030 |
Why?
| Animals | 1 | 2009 | 13124 | 0.030 |
Why?
| Pregnancy Trimester, Second | 1 | 2013 | 20 | 0.030 |
Why?
| Exercise | 1 | 2018 | 516 | 0.030 |
Why?
| Health Status | 1 | 2015 | 299 | 0.030 |
Why?
| Marijuana Abuse | 1 | 2015 | 154 | 0.030 |
Why?
| Trismus | 1 | 2012 | 2 | 0.030 |
Why?
| Multivariate Analysis | 1 | 2014 | 583 | 0.030 |
Why?
| Radiotherapy, Adjuvant | 1 | 2012 | 64 | 0.020 |
Why?
| Ultrasonography | 1 | 2014 | 435 | 0.020 |
Why?
| Chemoradiotherapy | 1 | 2012 | 42 | 0.020 |
Why?
| Least-Squares Analysis | 1 | 2011 | 40 | 0.020 |
Why?
| Enteral Nutrition | 1 | 2012 | 150 | 0.020 |
Why?
| Deglutition Disorders | 1 | 2012 | 77 | 0.020 |
Why?
| Pharmaceutical Services | 1 | 2011 | 52 | 0.020 |
Why?
| Urban Population | 1 | 2012 | 151 | 0.020 |
Why?
| Carcinoma | 1 | 2012 | 137 | 0.020 |
Why?
| Weight Gain | 1 | 2012 | 237 | 0.020 |
Why?
| Students, Pharmacy | 1 | 2011 | 124 | 0.020 |
Why?
| Socioeconomic Factors | 1 | 2011 | 591 | 0.020 |
Why?
| Child, Preschool | 1 | 2017 | 3942 | 0.020 |
Why?
| Patient Acceptance of Health Care | 1 | 2011 | 342 | 0.020 |
Why?
| Observer Variation | 1 | 2008 | 139 | 0.020 |
Why?
| Age Factors | 1 | 2011 | 1110 | 0.020 |
Why?
| Cell Nucleus | 1 | 2008 | 182 | 0.020 |
Why?
| Polytetrafluoroethylene | 1 | 2007 | 32 | 0.020 |
Why?
| Vascular Patency | 1 | 2007 | 83 | 0.020 |
Why?
| Biocompatible Materials | 1 | 2007 | 66 | 0.020 |
Why?
| Double-Blind Method | 1 | 2007 | 708 | 0.020 |
Why?
| Lymphatic Metastasis | 1 | 2003 | 222 | 0.010 |
Why?
| Survival Analysis | 1 | 2003 | 661 | 0.010 |
Why?
| Flow Cytometry | 1 | 2003 | 474 | 0.010 |
Why?
|
|
Ounpraseuth's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|